S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
ADTX$0.0004
Aditxt, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: OTC
Mkt Cap:$399.2K
Float & O/S:
Inst Own:
DilutionScan read 67 of Aditxt, Inc.'s SEC filings and found 7 warrant series, 7 convertibles, 1 ATM program, 1 equity line, 3 shelf registrations, 1 S-1 registration and 6 completed offerings on file for ADTX. The latest dilution event on file is an offering on Jul 16, 2026. Analysis updated Oct 15, 2026.
Signal8 Summary
ADTX
Delisting confirmed and going-concern warning
Snapshot
Aditxt is a biotech in extreme distress. FY 2025 revenue was just $3,000 while the company lost $41.7 million, and it has already overrun its cash runway with only $3.2 million remaining.
What's Happening Right Now
- : The Nasdaq Hearings Panel denied Aditxt's request to maintain its listing, confirming that trading will be suspended effective June 25, 2026.
- : Aditxt issued senior secured convertible notes with a 35% original issue discount to consolidate and refinance existing debt.
- : Founding CEO Amro Albanna, COO Rowena Albanna, and two board members resigned in a sweeping leadership overhaul.
Raise routes on file: active ATM + effective shelf + effective S-1 + active equity line · latest dilution event 110 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Jul 16, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Effective
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
July Warrants (July 2024 Senior Notes)
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Series C-1 Warrants (May 2024 Series C-1 Preferred PIPE)
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Warrant
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Consultant warrants (June 24, 2025)
Issued 2025
Shares Underlying
Exercise Price
Outstanding
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Series A-1 Convertible Preferred Stock
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Convertible
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Series A-2 Convertible Preferred Stock
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Series B-1 Convertible Preferred Stock
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
Series B-2 Convertible Preferred Stock
Principal
Conversion Price
Remaining principal
- Shares on conversion
- Interest rate
- Maturity
ATM program
Issued 2022
Total capacity
Sold to date
Remaining capacity
- Sales agent
- Agreement date
- Commission
Equity line
Issued 2024
Commitment
Sold to date
Remaining
- Agreement date
- Term ends
- Discount
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2024
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
S-3 shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
PIPE
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
PIPE
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Offering
Issued 2026
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your ADTX trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
